SEC Form 4 · accession 0001209191-17-046347
Pacira BioSciences, Inc. · PCRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David M Stack
Officer — CEO and Chairman · Director
Period of report
Jul 24, 2017
Accepted (ET)
Jul 26, 2017 · 5:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001396814
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 24, 2017 | M | 15,000 | $1.61 | A | 130,279 | D | |
| Common StockF2 | holding | — | — | — | 18,596 | I | By Stack Schroon Mohawk FLP | |
| Common StockF2 | holding | — | — | — | 1,208 | I | By LCK Investment LLC |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $1.61 | Jul 24, 2017 | M | 15,000 | D | — | Sep 2, 2020 | Common Stock | 15,000 | 140,960 | D |
Explanation of responses
- F1Includes 220 shares of common stock acquired under the issuer's employee stock purchase plan in June 2017.
- F2Mr. Stack is the general partner of Stack Schroon Mohawk FLP. Mr. Stack and his wife are the owners of LCK Investment LLC.
- F3The option vested as to 50% of the option shares on February 2, 2011, 19,378 option shares vested on February 3, 2011, and the remaining option shares vested in successive monthly installments for the subsequent 19 months.